Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

NCT01587586

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • National Taiwan University Hospital - Yunlin Douliu, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation - Kaohsiung Kaohsiung City, Taiwan
View all 13 locations
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

NCT03180619

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Coalition of Inclusive Medicine Los Angeles, California, United States
  • Silicon Valley Research Institute, Inc San Jose, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Harborview Medical Center Seattle, Washington, United States
View all 30 locations
View Trial Details
Completed

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

NCT03868163

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C (CHC), +15 more
Locations
  • LLC Medical Company Hepatolog /ID# 212384 Samara, Samara Oblast, Russia
  • Professor Pasechnikov Gastroenterology and Pankreatology clinic /ID# 217035 Stavropol, Stavropol Kray, Russia
  • A. F. Agafonov Republican Clin /ID# 212381 Kazan', Tatarstan, Respublika, Russia
  • South Ural State Medical univ /ID# 212020 Chelyabinsk, Russia
View Trial Details
Completed

A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

NCT04248426

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Altasciences Montreal, Quebec, Canada
  • Republican Clinical Hospital "Timofei Mosneaga" Arensia EM Unit Chisinau, Republic of Moldova, Moldova
  • Medical Center of Limited Liability Company "Harmoniya krasy" Department of Clinical Trials Kyiv, Ukraine
View Trial Details

Related conditions